When it comes to transcatheter aortic valve replacement (TAVR) technology, St. Jude is less upbeat than Medtronic, Edwards, or Boston Scientific. While those companies proudly announced positive data from their TAVR products at the Transcatheter Cardiovascular Therapeutics event in Washington D.C., St. Jude declared that it was temporarily halting implants of its Portico transcatheter aortic valve replacement (TAVR) devices after it spotted a problem with the devices.
Hey, check out all the engineering jobs. Post your resume today!
